These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33889425)

  • 1. Rationale for and Practical Use of Sacubitril/Valsartan in the Patient's Journey with Heart Failure and Reduced Ejection Fraction.
    Gori M; Januzzi JL; D'Elia E; Lorini FL; Senni M
    Card Fail Rev; 2021 Mar; 7():e06. PubMed ID: 33889425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sacubitril-valsartan in heart failure: a meta-analysis of randomized controlled trials.
    Zhang H; Huang T; Shen W; Xu X; Yang P; Zhu D; Fang H; Wan H; Wu T; Wu Y; Wu Q
    ESC Heart Fail; 2020 Dec; 7(6):3841-3850. PubMed ID: 32977362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data.
    Cuthbert JJ; Pellicori P; Clark AL
    Ther Clin Risk Manag; 2020; 16():715-726. PubMed ID: 32848403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining angiotensin II receptor 1 antagonism and neprilysin inhibition for the treatment of heart failure.
    Katsanos S; Bistola V; Parissis JT
    Expert Rev Clin Pharmacol; 2016 Apr; 9(4):513-523. PubMed ID: 26873036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction.
    Dewan P; Docherty KF; McMurray JJV
    Korean Circ J; 2019 Jun; 49(6):469-484. PubMed ID: 31172710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacubitril/valsartan in everyday clinical practice: an observational study based on the experience of a heart failure clinic.
    Cabral J; Vasconcelos H; Maia-Araújo P; Moreira E; Campelo M; Amorim S; Sousa A; Moura B; Pinto R; Dias C; Silva-Cardoso J
    Cardiovasc Diagn Ther; 2021 Dec; 11(6):1217-1227. PubMed ID: 35070791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension.
    Wu AH; Lin ZW; Yang ZH; Zhang H; Hu JY; Wang Y; Tang R; Zhang XY; Ji XP; Lu HX
    J Geriatr Cardiol; 2023 Dec; 20(12):855-866. PubMed ID: 38161336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.
    Selvaraj S; Claggett B; Pozzi A; McMurray JJV; Jhund PS; Packer M; Desai AS; Lewis EF; Vaduganathan M; Lefkowitz MP; Rouleau JL; Shi VC; Zile MR; Swedberg K; Solomon SD
    Circulation; 2019 Oct; 140(17):1369-1379. PubMed ID: 31510768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date.
    Akbar S; Kabra N; Aronow WS
    Ther Clin Risk Manag; 2020; 16():681-688. PubMed ID: 32801725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacubitril/Valsartan: From Clinical Trials to Real-world Experience.
    Joly JM; Desai AS
    Curr Treat Options Cardiovasc Med; 2018 Apr; 20(6):45. PubMed ID: 29687191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure.
    Brioschi M; D'Alessandra Y; Mapelli M; Mattavelli I; Salvioni E; Eligini S; Mallia A; Ricci V; Gianazza E; Ghilardi S; Agostoni P; Banfi C
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure.
    Di Tano G; Di Lenarda A; Iacoviello M; Oliva F; Urbinati S; Aspromonte N; Cipriani M; Caldarola P; Murrone A; Gulizia MM; Colivicchi F; Gabrielli D
    Eur Heart J Suppl; 2021 Aug; 23(Suppl C):C176-C183. PubMed ID: 34456644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expect the Unexpected in the Medical Treatment of Heart Failure with Reduced Ejection Fraction: between Scientific Evidence and Clinical Wisdom.
    Seferovic PM; Polovina M; Milinkovic I; Anker S; Rosano G; Coats A
    Int J Heart Fail; 2021 Oct; 3(4):205-218. PubMed ID: 36262556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease.
    Arriola-Montenegro J; Beas R; Cerna-Viacava R; Chaponan-Lavalle A; Hernandez Randich K; Chambergo-Michilot D; Flores Sanga H; Mutirangura P
    World J Cardiol; 2023 Jul; 15(7):328-341. PubMed ID: 37576545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent and Upcoming Drug Therapies for Pediatric Heart Failure.
    Loss KL; Shaddy RE; Kantor PF
    Front Pediatr; 2021; 9():681224. PubMed ID: 34858897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing Heart Failure With Reduced Ejection Fraction in Patients With Chronic Kidney Disease: A Case-Based Approach and Contemporary Review.
    Barry AR
    CJC Open; 2022 Sep; 4(9):802-809. PubMed ID: 36148258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Focus: Should You Take Sacubitril/Valsartan if You Have Heart Failure With an Ejection Fraction >40% and Low Blood Pressure? An Explanation of the Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial.
    Hendren NS; Thibodeau JT
    J Card Fail; 2024 May; ():. PubMed ID: 38825176
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged First-Dose Hypotension Induced by Sacubitril/Valsartan.
    Hsiao FC; Chu PH
    Acta Cardiol Sin; 2018 Jan; 34(1):96-98. PubMed ID: 29375230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer RNA-derived small RNAs and their potential roles in the therapeutic heterogeneity of sacubitril/valsartan in heart failure patients after acute myocardial infarction.
    Su J; Cheng J; Hu Y; Yu Q; Li Z; Li J; Zheng N; Zhang Z; Yang J; Li X; Zhang Z; Wang Y; Zhu K; Du W; Chen X
    Front Cardiovasc Med; 2022; 9():961700. PubMed ID: 36247465
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.